During the six months ended March 31, 2019, we did not purchase or hold any derivative instruments for trading or speculative purposes.

In December 2018, we entered into foreign currency forwards to mitigate the exposure to exchange rate changes on inventory purchases in USD by our foreign subsidiaries. At March 31, 2019, the notional amount we held through these forwards, based upon exchange rates at March 31, 2019, was as follows (in thousands):

Notional Currency	Notional Amount
MXP	$	15,310
EUR		10,916
CAD		7,507
GBP		4,511
Total	$	38,244

We record quarterly, net of income tax, the changes in fair value related to the foreign currency forwards into AOCL. As the forwards are exercised, the realized value will be recognized into cost of goods sold based on inventory turns. Based on March 31, 2019 valuations and exchange rates, we expect to reclassify approximately $0.5 million into cost of goods sold over the next 12 months.

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $550 million (the “interest rate caps”) to mitigate the exposure to increasing interest rates in connection with our term loan B. The interest rate caps are comprised of individual caplets that expire ratably through June 30, 2023 and are designated as cash flow hedges. Accordingly, changes in fair value of the interest rate caps are recorded quarterly, net of income tax, and are included in AOCL. Over the next 12 months, we expect to reclassify approximately $0.5 million into interest expense, which represents the original value of the expiring caplets.

The table below presents the fair value of our derivative financial instruments (in thousands):

	Asset Derivatives					Liability Derivatives
	Classification	March 31, 2019		September 30, 2018		Classification	March 31, 2019		September 30, 2018
Derivatives designated as hedging instruments:
Interest rate caps	Other assets	$	1,636	$	8,367	N/A	$	—	$	—
Foreign exchange contracts	Other current assets		580		—	Accrued liabilities		333		—
		$	2,216	$	8,367		$	333	$	—

The effects of our derivative financial instruments on our condensed consolidated statements of earnings were not material for the three and six months ended March 31, 2019 and 2018.